rajasekharkakarla ☆ India, 2019-09-20 08:35 (1673 d 12:38 ago) Posting: # 20628 Views: 1,770 |
|
Dear All, As per FDA guidelines "We recommend that if the predose value is greater than 5 percent of Cmax, you drop the subject from all BE study evaluations". Is it applicable for fully replicated designs also, if i got greater than 5% Cmax in period 4 whether i need to exclude the subject from entire study or can we use available data for Swr calculations if subject completed two reference treatment periods. Thanks&Regards, Rajasekhar |